KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Repligen (RGEN) Operating Expenses (2016 - 2025)

Repligen (RGEN) has disclosed Operating Expenses for 16 consecutive years, with $180.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Operating Expenses fell 11.76% to $180.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $683.1 million, a 2.02% increase, with the full-year FY2025 number at $683.1 million, up 2.02% from a year prior.
  • Operating Expenses was $180.0 million for Q4 2025 at Repligen, up from $172.0 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $204.0 million in Q4 2024 to a low of $106.5 million in Q1 2021.
  • A 5-year average of $150.9 million and a median of $149.3 million in 2021 define the central range for Operating Expenses.
  • Peak YoY movement for Operating Expenses: surged 81.98% in 2021, then dropped 11.76% in 2025.
  • Repligen's Operating Expenses stood at $149.1 million in 2021, then fell by 7.49% to $137.9 million in 2022, then grew by 13.65% to $156.7 million in 2023, then soared by 30.18% to $204.0 million in 2024, then decreased by 11.76% to $180.0 million in 2025.
  • Per Business Quant, the three most recent readings for RGEN's Operating Expenses are $180.0 million (Q4 2025), $172.0 million (Q3 2025), and $168.5 million (Q2 2025).